Teliatry’s Vagus Nerve Stimulator (VNS) IPG, developed in collaboration with the Texas Biomedical Device Center, was designed to deliver precisely timed, digitally programmed current pulses to the vagus nerve, but could also be used off-label for other superficial (< 4cm deep) nerve stimulation. At 50X smaller than traditional VNS IPGs, this implantable stimulator is batteryless, wirelessly powered, and has integrated platinum electrodes, which allow it to be implanted directly on the nerve. A wearable transmitter powers and relays IPG communications securely to a Bluetooth-capable device. It has received 3 FDA IDE approvals for the indications of Spinal Cord Injury (SCI), PTSD, and Stroke rehabilitation.
Teliatry’s Peripheral Nerve Stimulation (PNS) system is based on the Class III VNS IPG that can deliver higher current up to 5mA pulses. It is built on Teliatry’s proprietary glass manufacturing neuromodulation platform.
Fully implantable device exploits the transparency of Teliatry’s glass encapsulation and delivers LED light from a completely wireless system built to Class III manufacturing standards.
Teliatry has adapted its VNS IPG to preclinical animal research. Due to the small form factor, it can be used for animal studies including small animal subjects like rodents. Our research IPG can be implanted or worn and provides wireless, digitally controlled current pulses to any electrodes. A transmitter is typically positioned near the experimental apparatus/cage to provide power to the IPG and relay communications to a PC.
The most complex AIMD in the world for restoring eyesight to the blind at the volume of a grain of rice
•Total implant volume of <0.01cc, 500X smaller than state-of-the-art.
•Independent, 676 penetrating electrode arrays on a 3mmX3mm footprint.
•Highest penetrating electrodes density at 100 electrode/mm2 compared to any other implant.
•Battery-less power and wireless communication.
•Ultra low power system design.
•Complete Class III medical device system undergoing human clinical trials in Belgium, Italy, and Israel with excellent early results.
Nanoretina is commercializing this advancement to restore functional vision.
Teliatry’s multichannel IPG is a full-featured, generic IPG that can be used for neuromodulation applications requiring multi-electrode leads (SCS, DBS, etc.). It is powered by a minuscule, state of art novel battery architecture. This IPG delivers up to 10 mA pulses at rates of up to 10 kHz to any pair of 16 channels, while still achieving a form factor 30X smaller than existing SCS IPGs with rechargeable battery. The IPG can also record form any-channel to monitor spontaneous nerve activity or CNAPs resulting from stimulation. It eliminates external wearables, requires a single incision minimally invasive surgery and the IPG’s Bluetooth antenna transmits data directly and securely to a nearby Bluetooth-capable mobile device. This disruptive technology at <1cc volume will enable multiple existing therapies and lays out the ground work for future minimally invasive therapeutics.
The MINDSS system is a cutting-edge next generation, non-surgical, neurotechnology Brain Machine Interface (BMI), under development for DARPA’s N3 program. This wearable system makes use of advanced magnetometry and acoustic technologies for bi-directional cortical communication where Teliatry is providing system integration and regulatory support for the team led by Teledyne Scientific & Imaging.
